Netherlands· NL-3b83c948c763
Albuman 200 g/l oplossing voor infusie
A albumin product containing humaan albumine, registered in Netherlands by Prothya Biosolutions Netherlands B.V.. The same ATC class is registered in 13 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Albumin is registered in 13 of 19 countries.
Countries holding a registration under ATC B05AA01 (albumin), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Albumin · ATC B05AA01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- HUMAAN ALBUMINE
- Manufacturer
- Prothya Biosolutions Netherlands B.V.
- Country
- Netherlands (NL)
- ATC code
- B05AA01
- ATC class
- Albumin
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id103595
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B05AA01
Albumin, as other registers publish it.
- FinlandAlbiominBiotest Pharma GmbH
- PolandAlbiomin 20%Biotest Pharma GmbH
- IcelandAlbumanProthya Biosolutions Netherlands B.V.
- FinlandAlbumanProthya Biosolutions Netherlands B.V.
- FinlandAlbumanProthya Biosolutions Netherlands B.V.
- NetherlandsAlbuman 40 g/l oplossing voor infusieProthya Biosolutions Netherlands B.V.
- DenmarkAlbumin "Baxalta"Baxalta Innovations GmbH
- DenmarkAlbumin "Baxalta"Baxalta Innovations GmbH
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/48c259dd-51c2-4701-951d-285763c55e4d GET /v1/drugs/48c259dd-51c2-4701-951d-285763c55e4d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oplossing voor infusie",
"route": "Intraveneus gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h103595_smpc.pdf",
"strength": null,
"atc_label": "Albumin",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg103595",
"excipients": [
"NATRIUMCHLORIDE",
"NATRIUMHYDROXIDE (E 524)",
"SODIUM CAPRYLATE (E 470A) (RI)",
"WATER VOOR INJECTIE",
"ZOUTZUUR (E 507)"
],
"substances": [
"HUMAAN ALBUMINE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h103595.pdf",
"authorised_at": "2009/06/15",
"procedure_number": "FI/H/0732/002",
"dispensing_status": "Uitsluitend recept",
"registration_number": "103595",
"additional_monitoring": "N"
}See everything about albumin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.